NCT04003597

Brief Summary

In the context of public health, reformulation of bread in terms of salt content remains an important measure to help achieve a reduction in salt intake in the population. Therefore, the aim of this study was to examine, using a 5-week cross-over design, food-based intervention trial, the potential for inclusion of 'low-salt' bread as part of a pragmatic reduced-salt diet on blood pressure (BP) in adults with slightly to moderately elevated BP. The study consisted of a randomized crossover trial of the effect of reduced-salt intake or usual-salt intake for 5 weeks on BP (as the primary outcome) in adults with slightly to moderately elevated BP (seated office systolic BP \>120 and \<160 mmHg or a diastolic BP \>80 and \<95 mmHg; identified by a pre-screening phase). Subjects were randomly assigned to the reduced-salt diet or their usual-salt diet (control) for 5 weeks, followed by crossover to the alternative dietary regimen for a further 5 weeks. Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (\<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt, if desired (optional); these were supplied regularly by the research staff. Subjects commencing the trial on the control diet were allowed to follow their usual diet but were asked to consume an in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g). Participants met the research staff weekly to receive breads and no-salt margarine/butter as well as luncheon meats (where applicable), and at these meetings the staff promoted compliance with the intervention and encouraged completion of the study protocol. BP and other assessments were made at baseline and at the end of week 5 and week 10.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2008

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2010

Completed
8.9 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 1, 2019

Completed
Last Updated

July 1, 2019

Status Verified

June 1, 2019

Enrollment Period

2.6 years

First QC Date

June 21, 2019

Last Update Submit

June 28, 2019

Conditions

Keywords

Low-salt breadDietary sodium restrictionPre-hypertensionHypertension stage 1

Outcome Measures

Primary Outcomes (1)

  • Systolic blood pressure at end of intervention periods

    Measured as seated office systolic blood pressure at end of usual salt dietary period and at end of reduced-salt dietary period

    After 5 weeks of intervention

Secondary Outcomes (11)

  • Diastolic blood pressure

    After 5 weeks of intervention

  • Urinary Calcium

    After 5 weeks of intervention

  • Urinary N-telopeptides of Type I collagen

    After 5 weeks of intervention

  • Serum Parathyroid Hormone

    After 5 weeks of intervention

  • Serum C-telopeptide of Type I collagen

    After 5 weeks of intervention

  • +6 more secondary outcomes

Study Arms (2)

Usual-salt diet

PLACEBO COMPARATOR

Usual-salt diet followed for 5 weeks

Other: Usual-salt diet

Reduced-salt diet

ACTIVE COMPARATOR

Reduced-salt diet followed for 5 weeks

Other: Reduced-salt diet

Interventions

Subjects followed their usual-salt diet but were asked to consume an equivalent in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g).

Usual-salt diet

Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food (salted and naturally salty) and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (\<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt if desired (optional).

Reduced-salt diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • consenting adult Caucasian men and women, aged ≤65 y;
  • a seated office systolic BP \>120 and \<160 mmHg and/or a diastolic BP \>80 and \<95 mmHg (based on the mean BP across 3 screening visits as part of a pre-intervention phase of the trial)
  • willing to consume study breads

You may not qualify if:

  • taking anti-hypertensive medication;
  • taking any medications known to interfere with blood pressure or calcium or bone metabolism;
  • Severe medical illness;
  • celiac disease;
  • hypercalcemia;
  • known intestinal malabsorption syndrome,
  • excessive alcohol use (\>14 drinks/week);
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Food and Nutritional Sciences, University College Cork

Cork, Ireland

Location

MeSH Terms

Conditions

HypertensionPrehypertension

Interventions

Diet, Sodium-Restricted

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Kevin D Cashman, PhD

    University College Cork

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The biochemical outcome measures were assessed by researchers masked to the phase of the cross-over intervention from which the samples were derived.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Food and Health

Study Record Dates

First Submitted

June 21, 2019

First Posted

July 1, 2019

Study Start

January 3, 2008

Primary Completion

July 30, 2010

Study Completion

July 30, 2010

Last Updated

July 1, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations